YorLabs is developing a zero CapEx, zero-footprint intracardiac echocardiography (ICE) system that enables single-operator controls for interventional cardiology and electrophysiology procedures. This solution addresses the inefficiencies and high costs associated with existing imaging systems, streamlining workflows and reducing procedural complexity.
Funding
$37.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current intracardiac echocardiography (ICE) systems used in interventional cardiology and electrophysiology are expensive and suboptimal, leading to workflow inefficiencies, cognitive overload, and procedural complexity. The lack of a standardized diagnostic platform for ICE contributes to increased costs and barriers to adoption.
Solution
YorLabs is developing an ICE system designed to address the limitations of existing imaging solutions. Their system offers single-operator controls and eliminates the need for capital expenditure and additional footprint. By streamlining workflows and reducing procedural complexity, the YorLabs ICE system aims to lower the barriers to device adoption in interventional cardiology and electrophysiology procedures.
Target Audience
The primary target audience includes interventional cardiologists and electrophysiologists seeking to improve the efficiency and reduce the cost of ICE procedures.
Features
- Single-operator controls for enhanced workflow efficiency
- Zero capital expenditure (CapEx) model
- Zero-footprint design for easy integration into existing clinical environments